Not Such a Bright Idea: The Uk Risk-Sharing Scheme for Beta Interferon and Glatiramer Acetate in Multiple Sclerosis

Practical Neurology ◽

10.1046/j.1474-7766.2003.01168.x ◽

2003 ◽

Vol 3 (4) ◽

pp. 194-195

Author(s):

Charles Warlow

Keyword(s):

Multiple Sclerosis ◽

Glatiramer Acetate ◽

Risk Sharing ◽

Beta Interferon ◽

Sharing Scheme ◽

Download Full-text

A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

Value in Health ◽

10.1016/j.jval.2015.09.2512 ◽

2015 ◽

Vol 18 (7) ◽

pp. A765-A766 ◽

Author(s):

M Sumra ◽

E Walters

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Glatiramer Acetate ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Sharing Scheme ◽

The Uk ◽

Download Full-text

The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis

Practical Neurology ◽

10.1136/practneurol-2015-001209 ◽

2015 ◽

Vol 16 (1) ◽

pp. 4-6 ◽

Author(s):

Martin Duddy ◽

Jacqueline Palace

Keyword(s):

Multiple Sclerosis ◽

Glatiramer Acetate ◽

Risk Sharing ◽

Interferon Beta ◽

Sharing Scheme ◽

Download Full-text

PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME

Value in Health ◽

10.1016/j.jval.2018.09.2020 ◽

2018 ◽

Vol 21 ◽

pp. S338

Author(s):

E Walters ◽

S. Al-Izki ◽

DK Dhiraj ◽

B. Rodgers-Gray

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Glatiramer Acetate ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Sharing Scheme ◽

The Uk ◽

Download Full-text

A DECADE OF DATA FOR THE UK MULTIPLE SCLEROSIS RISK–SHARING SCHEME

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp-2013-306573.174 ◽

2013 ◽

Vol 84 (11) ◽

pp. e2.84-e2

Author(s):

Martin Duddy ◽

Jackie Palace

Keyword(s):

Multiple Sclerosis ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Sharing Scheme ◽

Download Full-text

Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme

Multiple Sclerosis Journal - Experimental Translational and Clinical ◽

10.1177/2055217319893103 ◽

2019 ◽

Vol 5 (4) ◽

pp. 205521731989310

Author(s):

G Giovannoni ◽

PA Brex ◽

D Dhiraj ◽

J Fullarton ◽

M Freddi ◽

...

Keyword(s):

Multiple Sclerosis ◽

National Health Service ◽

Health Service ◽

Effective Treatment ◽

Risk Sharing ◽

Cost Effective ◽

Sharing Scheme ◽

Cost Effective Treatment ◽

The Uk ◽

Relapsing Multiple Sclerosis

Download Full-text

Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator

The Lancet Neurology ◽

10.1016/s1474-4422(15)00018-6 ◽

2015 ◽

Vol 14 (5) ◽

pp. 497-505 ◽

Author(s):

Jacqueline Palace ◽

Martin Duddy ◽

Thomas Bregenzer ◽

Michael Lawton ◽

Feng Zhu ◽

...

Keyword(s):

Multiple Sclerosis ◽

Cohort Study ◽

Cost Effectiveness ◽

Natural History ◽

Risk Sharing ◽

Interferon Beta ◽

Clinical Cohort ◽

Multiple Sclerosis Risk ◽

Sharing Scheme ◽

Download Full-text

Faculty Opinions recommendation of The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1144846.601932 ◽

2009 ◽

Author(s):

Klaus Schmierer ◽

Rachel Farrell

Keyword(s):

Multiple Sclerosis ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Sharing Scheme ◽

Early Results ◽

Monitoring Study ◽

Download Full-text

Faculty Opinions recommendation of Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4241956.4038054 ◽

2010 ◽

Author(s):

George Ebers ◽

Andrew Weir

Keyword(s):

Multiple Sclerosis ◽

Cohort Study ◽

Risk Sharing ◽

Clinical Cohort ◽

Multiple Sclerosis Risk ◽

Download Full-text

Continuing the multiple sclerosis risk sharing scheme is unjustified

BMJ ◽

10.1136/bmj.c1786 ◽

2010 ◽

Vol 340 (jun03 1) ◽

pp. c1786-c1786 ◽

Author(s):

C. McCabe ◽

J. Chilcott ◽

K. Claxton ◽

P. Tappenden ◽

C. Cooper ◽

...

Keyword(s):

Multiple Sclerosis ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Download Full-text

The multiple sclerosis risk sharing scheme

BMJ ◽

10.1136/bmj.c2882 ◽

2010 ◽

Vol 340 (jun03 1) ◽

pp. c2882-c2882 ◽

Author(s):

N. Scolding

Keyword(s):

Multiple Sclerosis ◽

Risk Sharing ◽

Multiple Sclerosis Risk ◽

Download Full-text